KMICB - Dapsone (shared care guidance)
KMICB Dapsone for use as a disease-modifying anti-rheumatic drug (DMARD) SCP June 2025 V1
KMICB Dapsone Shared Care Request Letter
KMICB Dapsone Shared Care Agreement Letter
KMICB Dapsone Shared Care Refusal Letter
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary